The idea of PLATINEA started during an AIMday in 2016. During this day, organizations, companies, authorities and researchers gathered to discuss current societal needs and issues. Among the issues discussed were the opportunity to stimulate further development of existing antibiotics and how to ensure the availability of some key antibiotics. It became clear that there are no existing systems or processes that identify the actual needs of antibiotics by the healthcare sector and link them to relevant skills and competences in academia and industry, to provide antibiotics that meet these needs. As a neutral party Uppsala University took the initiative to create a new platform, where companies, authorities and healthcare can discuss and collaborate in order to jointly address the problem of inappropriate use and insufficient availability of antibiotics. Funding from the innovation-supporting organization UU Innovation supported a preliminary study which established new contacts with suitable actors to start creating this new platform.
In 2017, the project was granted funding from Vinnova (Sweden's Innovation Agency). This gave the opportunity to build the platform with suitable partners and formulate the purpose for PLATINEA. The partners agreed to move on with four areas / work packages (WP1, WP2, WP3 & WP4) in order to contribute to improved availability and appropriate use of existing antibiotics in Sweden.
In December 2018, PLATINEA was granted further funding from Vinnova (2018-2020) and the collaboration platform PLATINEA consisting of 15 partners from academia, authorities, industry and healthcare was now up and running.
In 2021 Vinnova - Sweden's Innovation Agency funded PLATINEA once again through their fundings for Innovation enviroments within precision medicine. Today our cooperation platform consists of 21 partners.